Order Article Reprints

Lee T-H, Chen H-L, Chang H-M, Wu C-M, Wu K-L, Kuo C-Y, Wei P-J, Chen C-L, Liu H-L, Hung J-Y, et al. Impact of Smoking Status in Combination Treatment with EGFR Tyrosine Kinase Inhibitors and Anti-Angiogenic Agents in Advanced Non-Small Cell Lung Cancer Harboring Susceptible EGFR Mutations: Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2022; 11(12):3366. https://doi.org/10.3390/jcm11123366

Lee, Tai-Huang, Hsiao-Ling Chen, Hsiu-Mei Chang, Chiou-Mei Wu, Kuan-Li Wu, Chia-Yu Kuo, Po-Ju Wei, Chin-Ling Chen, Hui-Lin Liu, Jen-Yu Hung, and et al. 2022. "Impact of Smoking Status in Combination Treatment with EGFR Tyrosine Kinase Inhibitors and Anti-Angiogenic Agents in Advanced Non-Small Cell Lung Cancer Harboring Susceptible EGFR Mutations: Systematic Review and Meta-Analysis" Journal of Clinical Medicine 11, no. 12: 3366. https://doi.org/10.3390/jcm11123366

Lee, T.-H., Chen, H.-L., Chang, H.-M., Wu, C.-M., Wu, K.-L., Kuo, C.-Y., Wei, P.-J., Chen, C.-L., Liu, H.-L., Hung, J.-Y., Yang, C.-J., & Chong, I.-W. (2022). Impact of Smoking Status in Combination Treatment with EGFR Tyrosine Kinase Inhibitors and Anti-Angiogenic Agents in Advanced Non-Small Cell Lung Cancer Harboring Susceptible EGFR Mutations: Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 11(12), 3366. https://doi.org/10.3390/jcm11123366